KLK4 and cancer: Previous evaluations of the four kallikrein markers were limited to men undergoing sextant prostate biopsies (10–13), while the study reported herein has the added value of assessing the markers in the more contemporary extended 10-core biopsy protocol used in ProtecT (15), as this leads to higher rates of cancer detection (18,19).